XML 25 R14.htm IDEA: XBRL DOCUMENT v3.25.1
Earnings per share
 3 Months Ended
Mar. 31, 2025
Earnings per share [Abstract]  
Earnings per share
7. Earnings per share

The following table sets forth the reconciliation of basic and diluted weighted average shares outstanding:

   
Three Months Ended
  
   
March 31,
  
   
2025
    
2024
  
   
(In thousands, except per-share data)
  
       
Net income (loss)
  
$
19
    
$
(1,036
)
                 
Shares:
                
Basic:  Weighted average common shares outstanding
    
10,043
      
9,972
  
Add:  Dilutive effect of outstanding options and restricted stock units as determined by the treasury stock method
    
11
      
–
  
Diluted:  Weighted average common and common equivalent shares outstanding
    
10,054
      
9,972
  
                 
Net income (loss) per common share:
                
Basic
  
$
0.00
    
$
(0.10
)
Diluted
  
$
0.00
    
$
(0.10
)

The computation of basic net earnings per share for each period is computed by dividing earnings by the basic weighted average number of common shares outstanding during the period.  Diluted earnings per share is computed by dividing net earnings by the weighted average number of shares outstanding during the period increased by the number of additional shares that would have been outstanding related to potentially dilutive securities under the treasury stock method (including stock options, restricted stock units and performance stock units), if the impact is dilutive.

When the average market price of our common stock is lower than the exercise price of the related stock option during the period, the computation of diluted earnings per share excludes the effect of the potential exercise of these stock option awards because the effect of including these stock option exercises would be anti-dilutive. Furthermore, in periods when a net loss is reported, basic and diluted net loss per common share are calculated using the same method.

Anti-dilutive stock option awards excluded from the computation of earnings per dilutive share were 1.3 million and 1.5 million at March 31, 2025 and 2024, respectively. Anti-dilutive restricted stock awards excluded from the computation of earnings per dilutive share were 0.1 million and 0.2 million at March 31, 2025 and 2024, respectively. Anti-dilutive performance stock awards excluded from the computation of earnings per dilutive share (including performance stock awards whose performance conditions were not satisfied as of the end of the period) were zero and 0.1 million at March 31, 2025 and 2024, respectively.